Boone Capital Management LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Boone Capital Management LLC reported 13 stock positions worth $296.5 million. Its top holding was Unum (UNM) at 19.8% of the portfolio, followed by Globus Medical Class A (GMED, 15.9%) and Perrigo (PRGO, 8.9%). Compared with Q3 2024, it opened 2 new positions, sold out of 6, added to 5 and reduced 5. The biggest buy was Perrigo (PRGO, shares +126%) and the biggest sale an exit from Chemed (CHE).
- Most Recent 13F
- Q2 2026
- Location
- ATLANTA, GA
- CIK
- 0001882053
- Portfolio Value
- $296.5M (Q4 2024)
- SEC Filing
- 0001214659-25-002826 ↗ filed Feb 14, 2025
Holdings Value
Holdings 13 stocks · $296.5M
| UNM Unum Group | 19.80% | 803,865 | $58.7M | Reduce -16.6% |
| GMED Globus Medical Inc. Class A | 15.86% | 568,465 | $47.0M | Reduce -12.8% |
| PRGO Perrigo Co. PLC | 8.87% | 1,022,369 | $26.3M | Add +126.1% |
| MIRM Mirum Pharmaceuticals Inc. | 8.12% | 581,843 | $24.1M | Add +7.0% |
| MOH Molina Healthcare Inc. | 8.03% | 81,842 | $23.8M | Add +14.1% |
| CI The Cigna Group | 8.00% | 85,861 | $23.7M | Reduce -34.9% |
| OFIX Orthofix Medical Inc. | 6.23% | 1,057,313 | $18.5M | Add +13.6% |
| PNTG The Pennant Group Inc. | 5.74% | 641,255 | $17.0M | No change |
| BHVN Biohaven Ltd. | 4.55% | 361,420 | $13.5M | New |
| IDYA Ideaya Biosciences Inc. | 4.55% | 524,868 | $13.5M | Reduce -1.3% |
| IQV Iqvia Holdings Inc. | 3.79% | 57,141 | $11.2M | Reduce -15.4% |
| GNW Genworth Financial Inc. | 3.62% | 1,536,612 | $10.7M | New |
| VKTX Viking Therapeutics Inc. | 2.85% | 209,853 | $8.4M | Add +8.8% |
Portfolio Sells Q3 2024 → Q4 2024
| CHE Chemed Corp. | Sold out | 0.00% | −6.14 |
| DHR Danaher Corp. | Sold out | 0.00% | −4.42 |
| BAX Baxter International Inc. | Sold out | 0.00% | −4.35 |
| BERY Berry Global Group Inc. | Sold out | 0.00% | −4.32 |
| AMPH Amphastar Pharmaceuticals Inc. | Sold out | 0.00% | −3.98 |
| CI The Cigna Group | Reduce -34.9% | 8.00% | −3.85 |
| CERT Certara Inc. | Sold out | 0.00% | −1.64 |
| IQV Iqvia Holdings Inc. | Reduce -15.4% | 3.79% | −0.36 |
| IDYA Ideaya Biosciences Inc. | Reduce -1.3% | 4.55% | +0.18 |
| GMED Globus Medical Inc. Class A | Reduce -12.8% | 15.86% | +3.77 |
| UNM Unum Group | Reduce -16.6% | 19.80% | +4.95 |
Portfolio Buys Q3 2024 → Q4 2024
| PRGO Perrigo Co. PLC | Add +126.1% | 8.87% | +5.79 |
| BHVN Biohaven Ltd. | New | 4.55% | +4.55 |
| GNW Genworth Financial Inc. | New | 3.62% | +3.62 |
| MIRM Mirum Pharmaceuticals Inc. | Add +7.0% | 8.12% | +2.62 |
| OFIX Orthofix Medical Inc. | Add +13.6% | 6.23% | +2.46 |
| MOH Molina Healthcare Inc. | Add +14.1% | 8.03% | +1.63 |
| VKTX Viking Therapeutics Inc. | Add +8.8% | 2.85% | −0.32 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 16 | $427.5M | TFX, MIRM, CI, IONS, UNH |
| Q1 2026 | 13 | $326.4M | MIRM, IONS, CI, MDT, TFX |
| Q4 2025 | 15 | $318.6M | MDT, MIRM, IONS, CI, BMRN |
| Q3 2025 | 16 | $305.0M | MDT, MIRM, IONS, CI, BBIO |
| Q2 2025 | 11 | $233.2M | MDT, MIRM, BMRN, AVTR, UNM |
| Q1 2025 | 12 | $293.8M | UNM, MDT, MIRM, GMED, CI |
| Q4 2024 | 13 | $296.5M | UNM, GMED, PRGO, MIRM, MOH |
| Q3 2024 | 17 | $385.8M | UNM, GMED, CI, MOH, CHE |
| Q2 2024 | 19 | $383.4M | UNM, GMED, CI, MOH, DHR |
| Q1 2024 | 21 | $494.4M | UNM, CI, MOH, ENOV, BAX |